Correlation Between Virax Biolabs and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Eliem Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Eliem Therapeutics.
Diversification Opportunities for Virax Biolabs and Eliem Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Virax and Eliem is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Eliem Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.36 times more return on investment than Eliem Therapeutics. However, Virax Biolabs is 1.36 times more volatile than Eliem Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 218.00 in Virax Biolabs Group on August 30, 2024 and sell it today you would lose (11.00) from holding Virax Biolabs Group or give up 5.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Virax Biolabs Group vs. Eliem Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Eliem Therapeutics |
Virax Biolabs and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Eliem Therapeutics
The main advantage of trading using opposite Virax Biolabs and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Virax Biolabs vs. Ikena Oncology | Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. RenovoRx |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |